 ?您的位置：對照品 > 對照品 > 自制對照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：H291055 |
| 產(chǎn)品名稱：2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[4 |
| 產(chǎn)品CAS：41276-02-2 |
| 規(guī)格含量：25mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
H291055 |
| 名稱: |
2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one |
| 別名: |
NSC 350625; TIC10; ONC201 |
| CAS號: |
41276-02-2 |
| 分子式: |
C??H??N?O |
| 分子量: |
386.49 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3H)-one is a small molecule TRAIL gene induction by normal and tumor cells as an anticancer therapy. The compound identified as NSC 350625 was assigned the structure above for many years. The compound is correctly characterized as B285480. The resolution of this issue was recently highlighted in Chemical and Engeneering News 92(23) 32 (2014). |
| 參考文獻(xiàn) |
|
|
|
|
|
|
![2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[4](/uploads/allimg/191207/1_120GA03C029.png "2,6,7,8,9,10-Hexahydro-10-[(2-methylphenyl)methyl]-7-(phenylmethyl)-imidazo[1,2-a]pyrido[4")
